Topic

takeda

Displaying 10 out of 9 results

  1. FILE PHOTO: The logo of Takeda Pharmaceutical Co. is displayed at the company's news conferenc

    Takeda's Shire takeover to bring US$963 million fee bonanza

    Banks, law firms and other advisers stand to earn up to US$963 million in fees from Takeda Pharmaceutical's US$62 billion takeover of drugmaker ...
  2. FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Takeda sets vote date, aims to close US$62 billion Shire deal Jan. 8

    Japan's Takeda Pharmaceutical will hold an investor vote on its US$62 billion acquisition of Shire next month and aims to close the deal on Jan.
  3. FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Exclusive: Takeda to win EU approval for US$62 billion Shire deal - sources

    EU antitrust regulators are set to approve Japanese drugmaker Takeda Pharmaceutical's US$62-billion offer for London peer Shire on condition that ...
  4. FILE PHOTO - Takeda Pharmaceutical Co President and Chief Executive Officer Christophe Weber attend

    Takeda CEO confident of investor backing for US$62 billion Shire deal

    The boss of Japan's Takeda Pharmaceutical said on Monday he was confident of securing investor backing for its US$62 billion acquisition of ...
  5. FILE PHOTO: Shire branding is seen outside their offices in Dublin

    Takeda proposes sale of Shire drug to gain European approval

    Takeda Pharmaceutical Co Ltd has proposed to European regulators it could sell a Shire treatment in development due to concerns of overlap in ...
  6. FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Takeda gets Japanese approval for US$62 billion Shire purchase

    Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its US$62 billion acquisition of Shire Plc , bringing ...
  7. FILE PHOTO: Shire branding is seen outside their offices in Dublin

    Takeda's US$62 billion Shire bid faces November 6 EU antitrust deadline

    EU antitrust regulators will decide by Nov. 6 whether to allow Japanese drugmaker Takeda Pharmaceutical's US$62-billion takeover of London-listed ...
  8. Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Takeda weighs sale of Shire's eye care business to cut debt: Bloomberg

    Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its US$62 billion purchase of the ...
  9. Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected

    Japan's Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater ...